Biowatch

Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC

Hanmi’s 'Amoprel' Makes Global Waves: World’s First Ultra-Low Triple Hypertension Drug Lands in JACC

The Phase 3 clinical trial results for Hanmi Pharmaceutical’s Amoprel—the world’s first ultra-low-dose triple antihypertensive drug—were published on...
VigenCell

VigenCell "Primary Endpoint Achieved"... Will a Domestic NK/T Lymphoma New Drug Be Born?

VigenCell has announced plans to apply for conditional approval within the year as it successfully completed commercialization clinical trials for...
Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic’s ‘Nesuparib’ Secures U.S. FDA Orphan Drug Designation for Small Cell Lung Cancer

Onconic Therapeutics announced on the 24th that its novel anti-cancer candidate, 'Nesuparib', has been designated as an...
A Ray of Hope: ‘Low Expression’ Changes the Landscape of Breast Cancer Treatment

A Ray of Hope: ‘Low Expression’ Changes the Landscape of Breast Cancer Treatment

The treatment landscape for metastatic breast cancer is undergoing a significant shift.
U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

U.S. and EU Escalate Pressure on China: A Turning Point for K-Bio?

As the United States prepares to announce the initial regulatory targets of the Biosecurity Act this week, market...
K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

K-Bio Targets Global Expansion: HK inno.N and HLB Seek FDA Approval

South Korean pharmaceutical and biotech companies are aggressively pursuing product approvals and clinical trials with...

"Wegovy is a No": A Comprehensive Look at Olympic Doping and Detection Technology

As the 2026 Milan-Cortina d'Ampezzo Winter Olympics continue, the world of sports is once again focused on the thin...
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January

Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer...
DNA in Blood Speaks of Cancer Traces

DNA in Blood Speaks of Cancer Traces

"Can we detect multiple cancers early with just one blood draw?" As interest grows in diagnostic tests that quickly...
ABL Bio Publishes Review Paper on Dual Antibodies in International Journal

ABL Bio Publishes Review Paper on Dual Antibodies in International Journal

ABL Bio announced on the 11th that it published a review paper on the next-generation immune-oncology dual antibody...